 Connection
Matthew Greenhawt to Adolescent
This is a "connection" page, showing publications Matthew Greenhawt has written about Adolescent.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.931 |
|
|
|
-
Abrams EM, Shaker M, Sinha I, Greenhawt M. COVID-19 vaccines: addressing hesitancy in young people with allergies. Lancet Respir Med. 2021 10; 9(10):1090-1092.
Score: 0.055
-
Greenhawt M, Shaker M, Stukus DR, Fleischer DM, Hourihane J, Tang MLK, Abrams EM, Wang J, Bingemann TA, Chan ES, Lieberman J, Sampson HA, Bock SA, Young MC, Waserman S, Mack DP. Managing Food Allergy in Schools During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020 10; 8(9):2845-2850.
Score: 0.051
-
Abrams EM, Greenhawt M. The role of peanut-free school policies in the protection of children with peanut allergy. J Public Health Policy. 2020 Jun; 41(2):206-213.
Score: 0.050
-
Shaker MS, Mosnaim G, Oppenheimer J, Stukus D, Abrams EM, Greenhawt M. Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2310-2321.e4.
Score: 0.050
-
Shaker M, Chalil JM, Tran O, Vlahiotis A, Shah H, King T, Green TD, Greenhawt M. Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy. Ann Allergy Asthma Immunol. 2020 04; 124(4):357-365.e1.
Score: 0.049
-
Shaker M, Greenhawt M. Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis. JAMA Netw Open. 2019 05 03; 2(5):e193242.
Score: 0.047
-
Shaker MS, Greenhawt MJ. Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. JAMA Pediatr. 2019 02 01; 173(2):169-175.
Score: 0.046
-
Shaker M, Greenhawt M. Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis. JAMA Netw Open. 2018 11 02; 1(7):e184728.
Score: 0.045
-
Greenhawt M, Wallace D, Sublett JW, Maughan E, Tanner A, Kelley KJ, Fineman S, White M, Cash G, Anderson C, Schoessler S, Gupta R, Pistiner M. Current trends in food allergy-induced anaphylaxis management at school. Ann Allergy Asthma Immunol. 2018 08; 121(2):174-178.
Score: 0.044
-
Wilson R, Greenhawt M. Influence of rhinitis control and inspiratory loop flattening on perceived asthma control. Ann Allergy Asthma Immunol. 2017 Oct; 119(4):387-389.
Score: 0.042
-
Karam M, Scherzer R, Ogbogu PU, Green TD, Greenhawt M. Food allergy prevalence, knowledge, and behavioral trends among college students - A 6-year comparison. J Allergy Clin Immunol Pract. 2017 Mar - Apr; 5(2):504-506.e5.
Score: 0.040
-
Ward CE, Greenhawt MJ. Treatment of allergic reactions and quality of life among caregivers of food-allergic children. Ann Allergy Asthma Immunol. 2015 Apr; 114(4):312-318.e2.
Score: 0.035
-
Greenhawt M. Food allergy quality of life. Ann Allergy Asthma Immunol. 2014 Nov; 113(5):506-12.
Score: 0.034
-
Rassbach W, Rubenstein JH, Elkins M, DeMatos V, Greenson JK, Greenhawt M. Age-based differences in the diagnosis and management of esophageal eosinophilia. J Allergy Clin Immunol Pract. 2015 Jan-Feb; 3(1):81-87.e1.
Score: 0.034
-
Holland CL, Samuels KM, Baldwin JL, Greenhawt MJ. Systemic reactions to inhalant immunotherapy using 1:1 target dosing. Ann Allergy Asthma Immunol. 2014 May; 112(5):453-8.
Score: 0.033
-
Gupta RS, Lau CH, Sita EE, Smith B, Greenhawt MJ. Factors associated with reported food allergy tolerance among US children. Ann Allergy Asthma Immunol. 2013 Sep; 111(3):194-198.e4.
Score: 0.031
-
Greenhawt M, MacGillivray F, Batty G, Said M, Weiss C. International study of risk-mitigating factors and in-flight allergic reactions to peanut and tree nut. J Allergy Clin Immunol Pract. 2013 Mar; 1(2):186-94.
Score: 0.030
-
Greenhawt MJ, Chernin AS, Howe L, Li JT, Sanders G. The safety of the H1N1 influenza A vaccine in egg allergic individuals. Ann Allergy Asthma Immunol. 2010 Nov; 105(5):387-93.
Score: 0.026
-
Golden DBK, Wang J, Waserman S, Akin C, Campbell RL, Ellis AK, Greenhawt M, Lang DM, Ledford DK, Lieberman J, Oppenheimer J, Shaker MS, Wallace DV, Abrams EM, Bernstein JA, Chu DK, Horner CC, Rank MA, Stukus DR, Burrows AG, Cruickshank H, Golden DBK, Wang J, Akin C, Campbell RL, Ellis AK, Greenhawt M, Lang DM, Ledford DK, Lieberman J, Oppenheimer J, Shaker MS, Wallace DV, Waserman S, Abrams EM, Bernstein JA, Chu DK, Ellis AK, Golden DBK, Greenhawt M, Horner CC, Ledford DK, Lieberman J, Rank MA, Shaker MS, Stukus DR, Wang J. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024 02; 132(2):124-176.
Score: 0.016
-
Maleki-Yazdi KA, Heen AF, Zhao IX, Guyatt GH, Suzumura EA, Makhdami N, Chen L, Winders T, Wheeler KE, Wang J, Spergel J, Silverberg JI, Ong PY, O'Brien M, Martin SA, Lio PA, Lind ML, LeBovidge J, Kim E, Huynh J, Greenhawt M, Frazier WT, Ellison K, Capozza K, De Benedetto A, Boguniewicz M, Begolka WS, Asiniwasis RN, Schneider LC, Chu DK. Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic Review. JAMA Dermatol. 2023 03 01; 159(3):320-330.
Score: 0.015
-
Alqurashi W, Shaker M, Wells GA, Collins GS, Greenhawt M, Curran JA, Zemek R, Schuh S, Ellis A, Gerdts J, Kreviazuk C, Dixon A, Eltorki M, Freedman SB, Gravel J, Poonai N, Worm M, Plint AC. Canadian Anaphylaxis Network-Predicting Recurrence after Emergency Presentation for Allergic REaction (CAN-PREPARE): a prospective, cohort study protocol. BMJ Open. 2022 10 31; 12(10):e061976.
Score: 0.015
-
Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, Blyuss O, El-Taravi Y, DunnGalvin A, Comberiati P, Peroni DG, Apfelbacher C, Genuneit J, Mazankova L, Miroshina A, Chistyakova E, Samitova E, Borzakova S, Bondarenko E, Korsunskiy AA, Konova I, Hanson SW, Carson G, Sigfrid L, Scott JT, Greenhawt M, Whittaker EA, Garralda E, Swann OV, Buonsenso D, Nicholls DE, Simpson F, Jones C, Semple MG, Warner JO, Vos T, Olliaro P, Munblit D. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022 Feb; 59(2).
Score: 0.014
-
Abrams EM, Greenhawt M, Shaker M, Alqurashi W. Separating Fact from Fiction in the Diagnosis and Management of Food Allergy. J Pediatr. 2022 02; 241:221-228.
Score: 0.014
-
Chen G, DunnGalvin A, Greenhawt M, Shaker M, Campbell DE. Deriving health utility indices from a food allergy quality-of-life questionnaire. Pediatr Allergy Immunol. 2021 11; 32(8):1773-1780.
Score: 0.014
-
Abrams EM, Shaker M, Greenhawt M, Fernandes RM, Sinha I. Treatment of mild-to-moderate asthma in childhood and adolescence in 2021. Lancet Respir Med. 2021 05; 9(5):443-445.
Score: 0.013
-
Nekliudov NA, Blyuss O, Cheung KY, Petrou L, Genuneit J, Sushentsev N, Levadnaya A, Comberiati P, Warner JO, Tudor-Williams G, Teufel M, Greenhawt M, DunnGalvin A, Munblit D. Excessive Media Consumption About COVID-19 is Associated With Increased State Anxiety: Outcomes of a Large Online Survey in Russia. J Med Internet Res. 2020 09 11; 22(9):e20955.
Score: 0.013
-
Fleischer DM, Shreffler WG, Campbell DE, Green TD, Anvari S, Assa'ad A, B?gin P, Beyer K, Bird JA, Brown-Whitehorn T, Byrne A, Chan ES, Cheema A, Chinthrajah S, Chong HJ, Davis CM, Ford LS, Gagnon R, Greenhawt M, Hourihane JO, Jones SM, Kim EH, Lange L, Lanser BJ, Leonard S, Mahler V, Maronna A, Nowak-Wegrzyn A, Oriel RC, O'Sullivan M, Petroni D, Pongracic JA, Prescott SL, Schneider LC, Smith P, Staab D, Sussman G, Wood R, Yang WH, Lambert R, Peillon A, Bois T, Sampson HA. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results. J Allergy Clin Immunol. 2020 10; 146(4):863-874.
Score: 0.013
-
Nguyen N, Lavery WJ, Capocelli KE, Smith C, DeBoer EM, Deterding R, Prager JD, Leinwand K, Kobak GE, Kramer RE, Menard-Katcher C, Furuta GT, Atkins D, Fleischer D, Greenhawt M, Friedlander JA. Transnasal Endoscopy in Unsedated Children With Eosinophilic Esophagitis Using Virtual Reality Video Goggles. Clin Gastroenterol Hepatol. 2019 11; 17(12):2455-2462.
Score: 0.011
-
Kao LM, Greenhawt MJ, Warren CM, Siracusa M, Smith BM, Gupta RS. Parental and parent-perceived child interest in clinical trials for food allergen immunotherapy. Ann Allergy Asthma Immunol. 2018 03; 120(3):331-333.e1.
Score: 0.011
-
DunnGalvin A, Polloni L, Le Bovidge J, Muraro A, Greenhawt M, Taylor S, Baumert J, Burks W, Trace A, DunnGalvin G, Forristal L, McGrath L, White J, Vasquez M, Allen K, Sheikh A, Hourihane J, Tang MLK. Preliminary Development of the Food Allergy Coping and Emotions Questionnaires for Children, Adolescents, and Young People: Qualitative Analysis of Data on IgE-Mediated Food Allergy from Five Countries. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):506-513.e11.
Score: 0.011
-
Robinson M, Greenhawt M, Stukus DR. Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department. Ann Allergy Asthma Immunol. 2017 08; 119(2):164-169.
Score: 0.010
-
Gupta RS, Walkner MM, Greenhawt M, Lau CH, Caruso D, Wang X, Pongracic JA, Smith B. Food Allergy Sensitization and Presentation in Siblings of Food Allergic Children. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):956-62.
Score: 0.010
-
Baptist AP, Dever SI, Greenhawt MJ, Polmear-Swendris N, McMorris MS, Clark NM. A self-regulation intervention can improve quality of life for families with food allergy. J Allergy Clin Immunol. 2012 Jul; 130(1):263-5.e6.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|